BW-501C67

BW-501C67 is a peripherally selective serotonin 5-HT 2A and 5-HT 2C receptor antagonist which is used in scientific research.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 1 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

BW-501C67 is a peripherally selective serotonin 5-HT 2A and 5-HT 2C receptor antagonist which is used in scientific research. It shows selectivity for the serotonin 5-HT 2 receptors over the α 1 -adrenergic receptor. The drug antagonizes peripheral but not central effects of serotonin receptor agonists like serotonin.

As examples, it has been found to antagonize the sympathomimetic effects of serotonin in animals, including vasoconstriction and pressor effects, but does not block centrally mediated effects like increased corticosterone secretion or myoclonus. BW-501C67 and analogues were patented for use in combination with serotonin 5-HT 2A receptor agonists like serotonergic psychedelics in 2023.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1333267544 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

1 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.